The target trial emulation study suggests rigid risk thresholds aren’t needed to steer statin use in this group.

Empagliflozin vs placebo was associated with greater reductions in risk for cardiovascular disease among patients with type 1 diabetes. Sodium–glucose cotransporter inhibitors (SGLTis) are associated ...

Cardiovascular disease (CVD) is a potential adverse effect of endocrine treatment (ET) for prostate cancer (PC). We investigated absolute and relative CVD risk in 76,600 patients with PC undergoing ET ...

A new tool may help patients better understand their long-term cardiovascular risk, researchers said. Based on the standard PREVENT risk calculator, researchers developed population-based age- and sex ...

Please provide your email address to receive an email when new articles are posted on . PREVENT is an online calculator that evaluates 10- and 30-year absolute risk associated with ...

A comparison of two risk prediction tools used to calculate an individual's risk of developing cardiovascular disease (CVD) suggests that the long-term, 30-year risk should be considered in addition ...

CHD is a leading cause of death in industrialized nations. Hyperlipidemia with elevated serum total cholesterol, LDL-C and triglycerides is a known major cardiovascular risk factor. HDL-C is ...

4 Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Providencia, Chile 5 Universidad de Santiago de Chile (USACH), Escuela de Ciencias de la Actividad Física, el Deporte y la Salud, ...

Credit: Getty Images Steven Grinspoon, MD, and Matthew J Feinstein, MD, MSc, discuss ways to reduce CVD risk in patients with HIV. While further research is needed to elucidate the nature of CVD in ...